We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Cambridge Cognition Holdings Plc | LSE:COG | London | Ordinary Share | GB00B8DV9647 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 52.00 | 51.00 | 53.00 | 52.00 | 52.00 | 52.00 | 218 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | 12.61M | -409k | -0.0117 | -44.44 | 18.12M |
From Apr 2019 to Apr 2024
TIDMCOG
RNS Number : 6573S
Cambridge Cognition Holdings PLC
12 March 2019
Cambridge Cognition Holdings Plc
('Cambridge Cognition' or the 'Company')
Director/PDMR Shareholdings
Further to the Fundraising announced on 7 March 2019, Cambridge Cognition Holdings plc, which develops and markets neuroscience technology to assess brain health, confirms the following disclosures by persons discharging managerial responsibilities.
The information below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
Hot Features
Premium
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Steven Powell
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status PDMR - Chief Executive Officer
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Cambridge Cognition Holdings Plc
------------------------------- ----------------------------------
b) LEI 213800SZKDIN122EPA96
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
Financial instrument,
type of instrument
Identification code GB00B8DV9647
------------------------------- ----------------------------------
b) Nature of the transaction Subscription for Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
72p 20,834
----------
------------------------------- ----------------------------------
d) Aggregated information: Subscription for 20,834 ordinary
* Aggregated volume shares at a price of 72p each
* Price
------------------------------- ----------------------------------
e) Date of the transaction 12 March 2019
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
1 Details of the person discharging managerial responsibilities
("PDMR") / person closely associated ("PCA")
a) Name Nick Walters
------------------------------- ----------------------------------
2. Reason for the Notification
-------------------------------------------------------------------
a) Position/status PDMR - Chief Financial Officer
------------------------------- ----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- ----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Cambridge Cognition Holdings Plc
------------------------------- ----------------------------------
b) LEI 213800SZKDIN122EPA96
------------------------------- ----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the Ordinary Shares of 1 pence each
Financial instrument,
type of instrument
Identification code GB00B8DV9647
------------------------------- ----------------------------------
b) Nature of the transaction Subscription for Ordinary Shares
------------------------------- ----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
72p 13,889
----------
------------------------------- ----------------------------------
d) Aggregated information: Subscription for 13,889 ordinary
* Aggregated volume shares at a price of 72p each
* Price
------------------------------- ----------------------------------
e) Date of the transaction 12 March 2019
------------------------------- ----------------------------------
f) Place of the transaction London Stock Exchange, AIM Market
(XLON)
------------------------------- ----------------------------------
Enquiries
Cambridge Cognition Holdings PLC Tel: 01223 810 700 Steven Powell, Chief Executive Officer press@camcog.com Nick Walters, Chief Financial Officer finnCap Ltd (NOMAD and Joint Broker) Tel: 020 7220 0500 Geoff Nash / Simon Hicks (Corporate Finance) Alice Lane / Manasa Patil (Corporate Broking) Dowgate Capital Limited (Joint Broker) Tel: 020 3903 7715 David Poutney / James Serjeant IFC Advisory Ltd (Financial PR and IR) Tel: 020 3934 6630 Graham Herring / Miles Nolan / Zach Cohen
About Cambridge Cognition
Cambridge Cognition is a neuroscience technology company developing digital health products to better understand, detect and treat conditions affecting brain health. The company's software products assess cognitive health in patients worldwide to improve clinical trial outcomes, identify and stratify patients early, and reduce global R&D and healthcare costs.
For further information visit www.cambridgecognition.com
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
DSHDLLFFKXFLBBB
(END) Dow Jones Newswires
March 12, 2019 13:23 ET (17:23 GMT)
1 Year Cambridge Cognition Chart |
1 Month Cambridge Cognition Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
